City

Shijiazhuang (2)

Guangzhou (1)

Shenzhen (1)

Condition

B-Cell Leukemia (1)

B-Cell Lymphoma (1)

B-cell Leukemia (1)

Overall Status

Recruiting (1)

Unknown status (1)

Sign in for free

Phase

phase 1/phase 2 (2)

Sponsor

Hebei Senlang Biotechnology Inc., Ltd. (1)

Shenzhen Geno-Immune Medical Institute (1)

Collaborator

The Second Hospital of Hebei Medical University (1)

Intervention

4scar-cd22/cd123/cd38/cd10/cd20/tslpr (1)

autologous cd19-targeting car t cells (1)

Study Documents

Intervention Type

biological (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

B-cell Leukemia

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

B-cell Leukemia Trial in Guangzhou, Shenzhen, Shijiazhuang (4SCAR-CD22/CD123/CD38/CD10/CD20/TSLPR)

Recruiting

B-cell Leukemia

4SCAR-CD22/CD123/CD38/CD10/CD20/TSLPR

Guangzhou, Guangdong, China
+2 more

Sep 18, 2019

B-Cell Leukemia, B-Cell Lymphoma Trial in Shijiazhuang (Autologous CD19-targeting CAR T cells)

Unknown status

B-Cell Leukemia
B-Cell Lymphoma

Autologous CD19-targeting CAR T cells

Shijiazhuang, Hebei, China

No.2 Hospital of Hebei Medical University

Apr 27, 2017